| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 2 642-646, Copyright © 1990 by American Association of Immunologists
ARTICLES |
T Fujisawa, R Abu-Ghazaleh, H Kita, CJ Sanderson and GJ Gleich
Division of Allergic Diseases, Mayo Clinic, Rochester, MN 55905.
We tested the effects of different cytokines on IgA- and IgG-induced eosinophil degranulation in vitro to determine the potential interaction between eosinophils and mononuclear cells. Purified normodense eosinophils were incubated with cytokines (including rIL-1, rIL-2, rIL-3, rIL-4, rIL-5, rIL-6, IFN-gamma, granulocyte-macrophage CSF stimulating factor (GM-CSF), and TNF) for 1 to 3 h after which Ig- coupled Sepharose 4B beads were added as targets and the mixtures were incubated with the eosinophils at 37 degrees C for 4 h. The Ig used were secretory IgA (sIgA), serum IgA and IgG, and myeloma IgA and IgG. The release of eosinophil-derived neurotoxin (EDN) was measured by RIA as an index of degranulation. rIL-5 was the most potent enhancer of Ig- induced degranulation and increased EDN release by 48% for sIgA and 136% for IgG. The effect of rIL-5 appeared as quickly as 15 min after incubation of eosinophils, sIgA beads and IL-5. GM-CSF and rIL-3 also enhanced Ig-induced EDN release but less potently than rIL-5. GM-CSF and rIL-5 by themselves induced a small but significant release of EDN from eosinophils in the absence of Ig-coated beads; rIL-3 did not. However, IFN-gamma suppressed sIgA-induced EDN release by 23%. The other cytokines did not have any effect on eosinophil degranulation. These results suggest that cytokines which induce eosinophil differentiation and proliferation during hematopoiesis also enhance the effector function of mature eosinophils and that IFN-gamma partially down-regulates eosinophil degranulation.
This article has been cited by other articles:
|
|
 |
|
  L. C. Smith and N. H. Cox Dapsone Treatment for Eosinophilic Fasciitis Arch Dermatol, July 1, 2008; 144(7): 845 - 847. [Full Text] [PDF]
|
|
|
|
 |
|
 W. ten Hove, L. A. Houben, J. A. M. Raaijmakers, L. Koenderman, and M. Bracke Rapid Selective Priming of Fc{alpha}R on Eosinophils by Corticosteroids J. Immunol., November 1, 2006; 177(9): 6108 - 6114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Z. Shi Eosinophils function as antigen-presenting cells J. Leukoc. Biol., September 1, 2004; 76(3): 520 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Clark, L. Simson, N. Newcombe, A. M. L. Koskinen, J. Mattes, N. A. Lee, J. J. Lee, L. A. Dent, K. I. Matthaei, and P. S. Foster Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen J. Leukoc. Biol., June 1, 2004; 75(6): 1001 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Thomas, W. Xu, and T. T. Ardon Immobilized Lactoferrin Is a Stimulus for Eosinophil Activation J. Immunol., July 15, 2002; 169(2): 993 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. BUSH, C. HOGG, and C. J CORRIGAN Oral steroids and inflammatory markers in asthma Arch. Dis. Child., May 1, 2001; 84(5): 450f - 450. [Full Text]
|
|
|
|
|
|
M. Thivierge, M. Doty, J. Johnson, J. Stankova, and M. Rola-Pleszczynski IL-5 Up-Regulates Cysteinyl Leukotriene 1 Receptor Expression in HL-60 Cells Differentiated into Eosinophils J. Immunol., November 1, 2000; 165(9): 5221 - 5226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-U. Simon, M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist J. Immunol., October 1, 2000; 165(7): 4069 - 4075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Cai, M. J. Spencer, G. Nakamura, L. Tseng-Ong, and J. G. Tidball Eosinophilia of Dystrophin-Deficient Muscle Is Promoted by Perforin-Mediated Cytotoxicity by T Cell Effectors Am. J. Pathol., May 1, 2000; 156(5): 1789 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Mould, A. J. Ramsay, K. I. Matthaei, I. G. Young, M. E. Rothenberg, and P. S. Foster The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity J. Immunol., February 15, 2000; 164(4): 2142 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suzuki, R. Taha, D. Ihaku, Q. Hamid, and J. G. Martin CD8+ T Cells Modulate Late Allergic Airway Responses in Brown Norway Rats J. Immunol., November 15, 1999; 163(10): 5574 - 5581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Han, J. H. Kim, Y. J. Noh, H. S. Chang, C. S. Kim, K.-S. Kim, S. Y. Ki, C. S. Park, and I. Y. Chung Interleukin (IL)-5 Downregulates Tumor Necrosis Factor (TNF)-Induced Eotaxin Messenger RNA (mRNA) Expression in Eosinophils . Induction of Eotaxin mRNA by TNF and IL-5 in Eosinophils Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 303 - 310. [Abstract] [Full Text]
|
|
|
|
|
|
E. Sato, K. L. Simpson, M. B. Grisham, S. Koyama, and R. A. Robbins Effects of Reactive Oxygen and Nitrogen Metabolites on RANTES- and IL-5-Induced Eosinophil Chemotactic Activity in Vitro Am. J. Pathol., August 1, 1999; 155(2): 591 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Adachi, S. Stafford, S. Sur, and R. Alam A Novel Lyn-Binding Peptide Inhibitor Blocks Eosinophil Differentiation, Survival, and Airway Eosinophilic Inflammation1, 2 J. Immunol., July 15, 1999; 163(2): 939 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ide, H. Hayakawa, T. Yagi, A. Sato, Y. Koide, A. Yoshida, M. Uchijima, T. Suda, K. Chida, and H. Nakamura Decreased Expression of Th2 Type Cytokine mRNA Contributes to the Lack of Allergic Bronchial Inflammation in Aged Rats J. Immunol., July 1, 1999; 163(1): 396 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Cowburn, S. T. Holgate, and A. P. Sampson IL-5 Increases Expression of 5-Lipoxygenase-Activating Protein and Translocates 5-Lipoxygenase to the Nucleus in Human Blood Eosinophils J. Immunol., July 1, 1999; 163(1): 456 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hisada, P. G. Hellewell, M. M. Teixeira, M. G. K. Malm, M. Salmon, T.-J. Huang, and K. Fan Chung alpha 4 Integrin-Dependent Eotaxin Induction of Bronchial Hyperresponsiveness and Eosinophil Migration in Interleukin-5 Transgenic Mice Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 992 - 1000. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Xiong, G. Karupiah, S. P. Hogan, P. S. Foster, and A. J. Ramsay Inhibition of Allergic Airway Inflammation in Mice Lacking Nitric Oxide Synthase 2 J. Immunol., January 1, 1999; 162(1): 445 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Motegi and H. Kita Interaction with Secretory Component Stimulates Effector Functions of Human Eosinophils But Not of Neutrophils J. Immunol., October 15, 1998; 161(8): 4340 - 4346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pazdrak, B. Olszewska-Pazdrak, S. Stafford, R. P. Garofalo, and R. Alam Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation J. Exp. Med., August 3, 1998; 188(3): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iikura, M. Yamaguchi, T. Fujisawa, M. Miyamasu, T. Takaishi, Y. Morita, T. Iwase, I. Moro, K. Yamamoto, and K. Hirai Secretory IgA Induces Degranulation of IL-3-Primed Basophils J. Immunol., August 1, 1998; 161(3): 1510 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Edgerton, P. Graber, D. Willard, T. Consler, M. McKinnon, I. Uings, C. Y. Arod, F. Borlat, R. Fish, M. C. Peitsch, et al. Spatial Orientation of the alpha and beta c Receptor Chain Binding Sites on Monomeric Human Interleukin-5 Constructs J. Biol. Chem., August 15, 1997; 272(33): 20611 - 20618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. de Andres, A. L. Mueller, A. Blum, J. Weinstock, S. Verbeek, M. Sandor, and R. G. Lynch Fcgamma RII (CD32) Is Linked to Apoptotic Pathways in Murine Granulocyte Precursors and Mature Eosinophils Blood, August 1, 1997; 90(3): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. McKinnon, K. Page, I. J. Uings, M. Banks, D. Fattah, A. E.I. Proudfoot, P. Graber, C. Arod, R. Fish, T. N.C. Wells, et al. An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils J. Exp. Med., July 7, 1997; 186(1): 121 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. de Groot, T. B. van Dijk, E. Caldenhoven, P. J. Coffer, J. A.M. Raaijmakers, J.-W. J. Lammers, and L. Koenderman Activation of 12-O-Tetradecanoylphorbol-13-acetate Response Element- and Dyad Symmetry Element-dependent Transcription by Interleukin-5 Is Mediated by Jun N-terminal Kinase/Stress-activated Protein Kinase Kinases J. Biol. Chem., January 24, 1997; 272(4): 2319 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Z. SHI, C.-Q. XIAO, D. ZHONG, S.-M. QIN, Y. LIU, G.-R. LIANG, H. XU, Y.-Q. CHEN, X.-M. LONG, and Z.-F. XIE Effect of Inhaled Interleukin-5 on Airway Hyperreactivity and Eosinophilia in Asthmatics Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 204 - 209. [Abstract] [Full Text]
|
|
|
|
|
|
E. Caldenhoven STAT3beta , a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription J. Biol. Chem., May 24, 1996; 271(22): 13221 - 13227. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Caldenhoven, T. van Dijk, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot Activation of the STAT3/Acute Phase Response Factor Transcription Factor by Interleukin-5 J. Biol. Chem., October 27, 1995; 270(43): 25778 - 25784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. England, P. Balasubramanian, I. Uings, S. Bethell, M.-J. Chen, P. J. Schatz, Q. Yin, Y.-F. Chen, E. A. Whitehorn, A. Tsavaler, et al. A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains PNAS, June 6, 2000; 97(12): 6862 - 6867. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
